Omeros (OMER) Debt Ratio (2010 - 2026)
Omeros (OMER) reported Debt Ratio of 0.18 for Q1 2026, down 62.42% on a YoY basis from 0.49 in Q1 2025, and down 12.18% sequentially from 0.21 in Q4 2025.
Omeros (OMER) Debt Ratio (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 62.42% year-over-year to 0.18; the trailing twelve-month figure through Mar 2026 stood at 0.18 (down 62.42% YoY), and the FY2025 full-year result was 0.21, down 40.08% from the prior year.
- Debt Ratio slipped to 0.18 in Q1 2026, from 0.21 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.91 in Q2 2022 to a low of 0.18 in Q1 2026.
- A 5-year average of 0.49 and a median of 0.49 in 2024 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio slumped 72.87% in 2022 and soared 64.13% in 2025, its largest moves.
- Tracing OMER's Debt Ratio over 5 years: stood at 0.53 in 2022, then grew by 20.41% to 0.64 in 2023, then plunged by 45.4% to 0.35 in 2024, then slumped by 40.08% to 0.21 in 2025, then dropped by 12.18% to 0.18 in 2026.
- Business Quant data shows OMER's Debt Ratio at 0.18 in Q1 2026, 0.21 in Q4 2025, and 0.39 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 0.21 |
| Sep 30, 2025 | 0.39 |
| Jun 30, 2025 | 0.44 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.35 |
| Sep 30, 2024 | 0.29 |
| Jun 30, 2024 | 0.27 |
| Mar 31, 2024 | 0.49 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | 0.91 |
| Mar 31, 2022 | 0.85 |
| Dec 31, 2021 | 0.75 |
| Sep 30, 2021 | 2.54 |
| Jun 30, 2021 | 2.15 |
| Mar 31, 2021 | 1.93 |